CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 1,200 enrolled
Drug / intervention
Hypoglycemia +4 morecombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03781713
NCT03781713Phase 2Completed
CompareCT.gov

Prospective Clinical Surveillance With Application of Trigger Tools in Critically Ill Patients

Hospital Sao Domingos·interventional·Posted Dec 20, 2018·Updated Dec 26, 2018

In Brief

A Phase 2 clinical trial evaluating KDIGO, Delta SOFA, and 3 other interventions for Critical Illness. Completed, enrolled 1,200 participants across 2 sites.

Detailed Summary

This study evaluates the impact of prospective clinical surveillance with the use of triggers to identify risk of adverse events with prompt adoption of interventions on the stabilization time of critically ill patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCritical Illness
CountriesBrazil
Collaborators--

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedDec 20, 2018
Enrollment StartNov 1, 2017
Primary CompletionOct 31, 2018
Study CompletionDec 10, 2018
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 7.5 years ago

Interventions

KDIGOother

Interventions to prevent renal replacement therapy

Delta SOFAother

interventions to improve SOFA score

Hypoglycemiacombination

Interventions to prevent new episodes of hypoglycemia in the next 24 hours

Drug interaction risk D or Xdrug

Intervention in the therapeutic plan in order to avoid adverse drug reactions.

Antimicrobial stewardshipdrug

Optimization of anticrobial therapy based on Gram stain, MALDI TOF, MIC and antimicrobial susceptibility